Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LBX Pharmacy Chain JSCSHSE:603883 -1.84%80 PEG Ratio is 1.56 as of Jul. 19, 2026, which is 4% above its 10-year median of 1.50. GuruFocus rates SHSE:603883 with a GF Score™ of 80/100 and a GF Value™ of ¥19.22 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 224 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks worse than 54.02% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for LBX Pharmacy Chain JSC's PEG Ratio or its related term are showing as below:
SHSE:603883'
s PEG Ratio Range Over the Past 10 Years
Min: 0.71 Med: 1.5 Max: 16.68
Current: 1.56
During the past 13 years, LBX Pharmacy Chain JSC's highest PEG Ratio was 16.68. The lowest was 0.71. And the median was 1.50.
SHSE:603883's PEG Ratio is ranked worse than 54.02% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.415
vs SHSE:603883: 1.56
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
LBX Pharmacy Chain JSC (SHSE:603883) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBX Pharmacy Chain JSC PEG Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's PEG Ratio distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
LBX Pharmacy Chain JSC (SHSE:603883) has a PEG Ratio of 1.56 as of Jul. 19, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on LBX Pharmacy Chain JSC and its competitors. This is near median its historical median of 1.50. Over the past decade, LBX Pharmacy Chain JSC's PEG Ratio has ranged from 0.71 to 16.68. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #121 out of 224 companies in the Healthcare Providers & Services industry, placing it in the top 54%.
Is LBX Pharmacy Chain JSC's PEG Ratio too high?
LBX Pharmacy Chain JSC's current PEG Ratio of 1.56 is near median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 16.68. The Healthcare Providers & Services industry median PEG Ratio is 1.42. LBX Pharmacy Chain JSC's value of 1.56 is 10.2% above this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #121 out of 224 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's PEG Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #121 out of 224 companies for PEG Ratio. This places LBX Pharmacy Chain JSC in the lower half of its industry. The industry median PEG Ratio is 1.42. LBX Pharmacy Chain JSC's value of 1.56 is 10.2% above this benchmark. Historically, LBX Pharmacy Chain JSC's own PEG Ratio has ranged from 0.71 to 16.68 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 1.42, LBX Pharmacy Chain JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.42, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current PEG Ratio of 1.56 is 10.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current PEG Ratio is 1.56, which is near median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.22, compared to a current price of ¥12.27 — trading 36.2% below its estimated fair value. The current PEG Ratio is 1.56, which is near median its 10-year median of 1.50 and 10.2% above the Healthcare Providers & Services industry median of 1.42. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current PEG Ratio is 1.56 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥12.27 is trading 36.2% below its estimated GF Value™ of ¥19.22.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
PEG Ratio: 1.56 (near median its 10-year median of 1.50)
GF Value™: ¥19.22 vs. price of ¥12.27 (36.2% below fair value)
Industry Position: 10.2% above the Healthcare Providers & Services median (#121 of 224)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score
Get the complete analysis for SHSE:603883
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
